VITROS IMMUNODIAGNOSTIC PRODUCTS/HBSAG REAGENT PACK,VITROS IMMUNODIAGNOSTIC PRODUCTS CONFIRMATORY KIT, AND VITROS IMMUNR

Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)

FDA Premarket Approval P000044

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the vitros immunodiagnostic products hbsag reagent pack, vitros immunodiagnostic products confirmatory kit, and vitros immunodiagnostic products calibrator. The vitros immunodiagnostics hbsag reagent pack is indicated for the in vitro qualitative detection of hepatitis b surface antigen (hbsag) in human serum and plasma (heparin, edta, and sodium citrate) using the vitros eci immunodiagnostic system. Assay results, in conjunction with other serological and clinical information, may be used for the laboratory diagnosis of individuals with acute or chronic hepatitis b. In addition, this assay may be used to screen for hepatitis b infection in pregnant women to identify neonates who are at high risk of acquiring hbv during the perinatal period. The vitros immunodiagnostic products hbsag calibrator is indicated for use in the calibration of the vitros immunodiagnostic system for the qualitative in vitro determination of hepatitis b surface antigen (hbsag) in human serum or plasma (heparin, edta, and sodium citrate) using vitros hbsag reagent packs. The vitros hbsag calibrator has been validated for use only on the vitros system with the vitros immunodiagnostic products hbsag reagent pack. Refer to the vitros hbsag reagent pack instructions for use for further details. The vtiros hbsag confirmatory kit is indicated for the qualitative confirmation of hepatitis b surface antigen (hbsag) in human serum and plasma (heparin, edta, and sodium citrate) specimens that have been found to be repeatedly reactive using the vitros immunodiagnostic products hbsag reagent pack and the vitros immunodiagnostic products hbsag calibrator. The vitros hbsag confirmatory kit is for use with the vitros eci immunodiagnostic system.

DeviceVITROS IMMUNODIAGNOSTIC PRODUCTS/HBSAG REAGENT PACK,VITROS IMMUNODIAGNOSTIC PRODUCTS CONFIRMATORY KIT, AND VITROS IMMUNR
Classification NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
Generic NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
ApplicantOrtho-Clinical Diagnostics, Inc.
Date Received2000-11-01
Decision Date2001-04-27
Notice Date2001-05-14
PMAP000044
SupplementS
Product CodeLOM
Docket Number01M-0226
Advisory CommitteeMicrobiology
Expedited ReviewNo
Combination Product No
Applicant Address Ortho-Clinical Diagnostics, Inc. 100 Indigo Creek Dr. rochester, NY 14626-5101
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P000044Original Filing
S040 2019-05-21 30-day Notice
S039 2018-10-16 Normal 180 Day Track No User Fee
S038 2018-02-21 Normal 180 Day Track No User Fee
S037 2018-01-09 Normal 180 Day Track No User Fee
S036 2017-10-17 30-day Notice
S035 2017-05-30 30-day Notice
S034 2016-03-02 30-day Notice
S033 2015-10-29 30-day Notice
S032 2015-08-10 30-day Notice
S031 2015-06-25 30-day Notice
S030 2012-10-17 30-day Notice
S029 2012-01-30 30-day Notice
S028 2011-10-05 Real-time Process
S027 2011-08-19 30-day Notice
S026 2011-04-28 30-day Notice
S025 2010-10-18 30-day Notice
S024 2010-08-06 30-day Notice
S023 2009-12-01 Normal 180 Day Track No User Fee
S022 2009-09-30 30-day Notice
S021 2009-03-06 30-day Notice
S020 2009-02-02 Normal 180 Day Track
S019 2008-11-13 Normal 180 Day Track No User Fee
S018 2008-05-15 30-day Notice
S017 2008-01-23 30-day Notice
S016 2007-03-21 30-day Notice
S015 2007-03-12 30-day Notice
S014 2006-08-08 30-day Notice
S013 2006-05-25 Real-time Process
S012 2006-05-12 30-day Notice
S011 2006-03-15 30-day Notice
S010 2005-11-18 30-day Notice
S009 2005-10-26 30-day Notice
S008 2005-09-02 30-day Notice
S007 2005-07-13 30-day Notice
S006 2005-04-08 Special (immediate Track)
S005 2004-11-15 30-day Notice
S004 2004-10-26 30-day Notice
S003 2003-03-06 30-day Notice
S002 2001-05-29 30-day Notice
S001 2001-05-04 30-day Notice

NIH GUDID Devices

Device IDPMASupp
10758750002764 P000044 030
10758750001088 P000044 030
10758750001071 P000044 030
10758750001064 P000044 030

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.